Skip to main content
. 2022 Feb 4;20:70. doi: 10.1186/s12967-021-03209-2

Table 2.

Categories of pathways predicted to involve the candidate drugs

Category Pathway name E-score* P value
Mitotic cell cycle Mitotic nuclear envelope disassembly − 0.73 5.63E−06
Mitotic cell cycle − 0.70 1.61E−05
G1/S transition of mitotic cell cycle − 0.59 5.60 E−04
Mitotic metaphase plate congression − 0.52 3.03 E−03
Mitotic sister chromatid segregation − 0.51 4.24 E−03
Regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle − 0.51 4.33 E−03
Negative regulation of mitotic cell cycle 0.50 4.76 E−03
Negative regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle − 0.47 1.04 E−02
Positive regulation of ubiquitin-protein ligase activity involved in mitotic cell cycle − 0.45 1.57 E−02
Mitotic cell cycle arrest 0.44 1.97 E−02
ER stress Endoplasmic reticulum unfolded protein response 0.70 1.49 E−05
Response to endoplasmic reticulum stress 0.66 6.22 E−05
Intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress 0.56 1.07 E−03
Glucose transport Regulation of glucose transport − 0.70 1.79 E−05
Glucose transport − 0.51 4.59 E−03
Negative regulation of glucose import 0.49 7.22 E−03
Cellular response to glucose starvation 0.46 1.37 E−02
Autophagy Positive regulation of autophagy 0.54 2.01 E−03
Autophagy 0.52 3.08 E−03
Regulation of autophagy 0.47 1.15 E−02

* Escore: Enrichment score from − 1 to + 1, refer to down/up-regulation

HHS Vulnerability Disclosure